Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 11

Therapeutics and Clinical Risk Management


Archive: Volume 11, 2015

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J

Therapeutics and Clinical Risk Management 2015, 11:1853-1861

Published Date: 17 December 2015

Are atrophic long-bone nonunions associated with low-grade infections?

Dapunt U, Spranger O, Gantz S, Burckhardt I, Zimmermann S, Schmidmaier G, Moghaddam A

Therapeutics and Clinical Risk Management 2015, 11:1843-1852

Published Date: 15 December 2015

Enema reduction of intussusception: the success rate of hydrostatic and pneumatic reduction

Khorana J, Singhavejsakul J, Ukarapol N, Laohapensang M, Wakhanrittee J, Patumanond J

Therapeutics and Clinical Risk Management 2015, 11:1837-1842

Published Date: 15 December 2015

The effect of low-sodium dialysate on ambulatory blood pressure measurement parameters in patients undergoing hemodialysis

Akdag S, Akyol A, Cakmak HA, Tosu AR, Asker M, Yaman M, Babat N, Soyoral Y, Cegin MB, Gur AK, Gumrukcuoglu HA

Therapeutics and Clinical Risk Management 2015, 11:1829-1835

Published Date: 11 December 2015

Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging

Zhang L, Liu Z, Hu KY, Tian QB, Wei LG, Zhao Z, Shen HR, Hu J

Therapeutics and Clinical Risk Management 2015, 11:1819-1827

Published Date: 10 December 2015

Lung ultrasound for the diagnosis of childhood pneumonia: a safe and accurate imaging mode

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2015, 11:1817-1818

Published Date: 9 December 2015

Docetaxel-related interstitial pneumonitis

Wang CJ, Chang HT, Chang CY

Therapeutics and Clinical Risk Management 2015, 11:1813-1816

Published Date: 9 December 2015

Hypercalcemia of malignancy and new treatment options

Sternlicht H, Glezerman IG

Therapeutics and Clinical Risk Management 2015, 11:1779-1788

Published Date: 4 December 2015

Profile of secukinumab in the treatment of psoriasis: current perspectives

Roman M, Madkan VK, Chiu MW

Therapeutics and Clinical Risk Management 2015, 11:1767-1777

Published Date: 2 December 2015

Bevacizumab for glioblastoma

Narita Y

Therapeutics and Clinical Risk Management 2015, 11:1759-1765

Published Date: 1 December 2015

The limits of oral therapy in pulmonary arterial hypertension management

Liu QQ, Jing ZC

Therapeutics and Clinical Risk Management 2015, 11:1731-1741

Published Date: 23 November 2015

Clinical development of nintedanib for advanced non-small-cell lung cancer

Takeda M, Okamoto I, Nakagawa K

Therapeutics and Clinical Risk Management 2015, 11:1701-1706

Published Date: 16 November 2015

Evidence-based treatments for cluster headache

Gooriah R, Buture A, Ahmed F

Therapeutics and Clinical Risk Management 2015, 11:1687-1696

Published Date: 9 November 2015

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes

Vallumsetla N, Paludo J, Kapoor P

Therapeutics and Clinical Risk Management 2015, 11:1663-1674

Published Date: 6 November 2015

The relationships between blood pressure, blood glucose, and bone mineral density in postmenopausal Turkish women

Cakmak HA, Cakmak BD, Yumru AE, Aslan S, Enhos A, Kalkan AK, Inci Coskun E, Acikgoz AS, Karatas S

Therapeutics and Clinical Risk Management 2015, 11:1641-1648

Published Date: 30 October 2015

Decompressive craniectomy for severe traumatic brain injury patients with fixed dilated pupils

Mao X, Miao G, Hao S, Tao X, Hou Z, Li H, Tian R, Zhang H, Lu T, Ma J, Zhang X, Cheng H, Liu B

Therapeutics and Clinical Risk Management 2015, 11:1627-1633

Published Date: 22 October 2015

Effect of fluid loading on left ventricular volume and stroke volume variability in patients with end-stage renal disease: a pilot study

Kanda H, Hirasaki Y, Iida T, Kanao-Kanda M, Toyama Y, Kunisawa T, Iwasaki H

Therapeutics and Clinical Risk Management 2015, 11:1619-1625

Published Date: 20 October 2015

The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus

Karagoz H, Erden A, Ozer O, Esmeray K, Cetinkaya A, Avci D, Karahan S, Basak M, Bulut K, Mutlu H, Simsek Y

Therapeutics and Clinical Risk Management 2015, 11:1613-1617

Published Date: 19 October 2015

Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

Colombo GL, Cammà C, Attili AF, Ganga R, Gaeta GB, Brancaccio G, Franzini JM, Volpe M, Turchetti G

Therapeutics and Clinical Risk Management 2015, 11:1603-1612

Published Date: 19 October 2015

Symptomatic flexible flatfoot in adults: subtalar arthroereisis

Ozan F, Doğar F, Gençer K, Koyuncu Ş, Vatansever F, Duygulu F, Altay T

Therapeutics and Clinical Risk Management 2015, 11:1597-1602

Published Date: 16 October 2015

Mandibular bone mineral density in patients with Behçet’s disease

Asutay F, Atalay Y, Acar AH, Asutay H, Eroğlu S, Burdurlu MÇ

Therapeutics and Clinical Risk Management 2015, 11:1587-1591

Published Date: 14 October 2015

Pulse oximetry in bronchiolitis: is it needed?

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2015, 11:1573-1578

Published Date: 12 October 2015

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Lombardo N, Maselli R

Therapeutics and Clinical Risk Management 2015, 11:1563-1572

Published Date: 8 October 2015

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer

Shimizu K, Okita R, Saisho S, Yukawa T, Maeda A, Nojima Y, Nakata M

Therapeutics and Clinical Risk Management 2015, 11:1555-1561

Published Date: 8 October 2015

Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosis

Chuang HC, Su CL, Liu HC, Feng PH, Lee KY, Chuang KJ, Lee CN, Bien MY

Therapeutics and Clinical Risk Management 2015, 11:1539-1544

Published Date: 6 October 2015

Acute gastrointestinal injury in the intensive care unit: a retrospective study

Chen HS, Zhang HD, Li W, Wu SN, Wang W

Therapeutics and Clinical Risk Management 2015, 11:1523-1529

Published Date: 5 October 2015

Anatomic and functional outcomes of retinectomy for the management of complicated retinal detachment with proliferative vitreoretinopathy

Tranos P, Vakalis A, Asteriadis S, Lokovitis E, Georgalas I, Stravrakas P

Therapeutics and Clinical Risk Management 2015, 11:1515-1521

Published Date: 3 October 2015

The potential of medical device industry in technological and economical context

Maresova P, Penhaker M, Selamat A, Kuca K

Therapeutics and Clinical Risk Management 2015, 11:1505-1514

Published Date: 3 October 2015

Surveillance of antibiotic and analgesic use in the Oral Surgery Department of the University Dentistry Clinical Center of Kosovo

Haliti NR, Haliti FR, Koçani FK, Gashi AA, Mrasori SI, Hyseni VI, Bytyqi SI, Krasniqi LL, Murtezani AF, Krasniqi SL

Therapeutics and Clinical Risk Management 2015, 11:1497-1503

Published Date: 1 October 2015

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention

Wang M, Zhang GR, Wang YL, Zhou K, Liu T, Zhang Y, Guo AJ, An Y, Zhang XD, Li YJ

Therapeutics and Clinical Risk Management 2015, 11:1469-1473

Published Date: 28 September 2015

Emerging therapeutic options for sporadic inclusion body myositis

Alfano LN, Lowes LP

Therapeutics and Clinical Risk Management 2015, 11:1459-1467

Published Date: 25 September 2015

Diagnosis and management of miliary tuberculosis: current state and future perspectives [Retraction]

Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N

Therapeutics and Clinical Risk Management 2015, 11:1457-1458

Published Date: 28 September 2015

Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controls

Hua XP, Zhang XD, Kwong JS, Zeng XT, Zhang ZJ, Wei WL

Therapeutics and Clinical Risk Management 2015, 11:1429-1436

Published Date: 23 September 2015

Optimizing clopidogrel dose response: a new clinical algorithm comprising CYP2C19 pharmacogenetics and drug interactions

Saab YB, Zeenny R, Ramadan WH

Therapeutics and Clinical Risk Management 2015, 11:1421-1427

Published Date: 23 September 2015

The clinical application of linagliptin in Asians

Cao CQ, Xiang YF, Zhou ZG

Therapeutics and Clinical Risk Management 2015, 11:1409-1419

Published Date: 16 September 2015

New advances in the treatment of generalized lipodystrophy: role of metreleptin

Rodriguez AJ, Mastronardi CA, Paz-Filho GJ

Therapeutics and Clinical Risk Management 2015, 11:1391-1400

Published Date: 16 September 2015

Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases

Tateiwa T, Takahashi Y, Ishida T, Kubo K, Masaoka T, Shishido T, Sano K, Yamamoto K

Therapeutics and Clinical Risk Management 2015, 11:1383-1389

Published Date: 15 September 2015

Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway

Zhao XJ, Hua Y, Chen HM, Yang HY, Zhang T, Huang GQ, Fan HJ, Tan ZB, Huang XF, Liu B, Zhou YC

Therapeutics and Clinical Risk Management 2015, 11:1371-1381

Published Date: 11 September 2015

A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature

Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H

Therapeutics and Clinical Risk Management 2015, 11:1361-1365

Published Date: 7 September 2015

The role of SDF-1/CXCR4 in the vasculogenesis and remodeling of cerebral arteriovenous malformation

Wang L, Guo S, Zhang N, Tao Y, Zhang H, Qi T, Liang F, Huang Z

Therapeutics and Clinical Risk Management 2015, 11:1337-1344

Published Date: 1 September 2015

Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis

Migliore A, Bizzi E, Egan CG, Bernardi M, Petrella L

Therapeutics and Clinical Risk Management 2015, 11:1325-1335

Published Date: 1 September 2015

National consumption of opioid and nonopioid analgesics in Croatia: 2007–2013

Krnic D, Anic-Matic A, Dosenovic S, Draganic P, Zezelic S, Puljak L

Therapeutics and Clinical Risk Management 2015, 11:1305-1314

Published Date: 28 August 2015

Validity of subjective smoking status in orthopedic patients

Bender D, Haubruck P, Boxriker S, Korff S, Schmidmaier G, Moghaddam A

Therapeutics and Clinical Risk Management 2015, 11:1297-1303

Published Date: 27 August 2015

Tracheobronchial foreign bodies in children – a retrospective study of 2,000 cases in Northwestern China

Liang JM, Hu J, Chang HM, Gao Y, Luo HN, Wang ZH, Zheng GX, Chen F, Wang T, Yang YY, Kou XH, Xu M

Therapeutics and Clinical Risk Management 2015, 11:1291-1295

Published Date: 28 August 2015

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link

Patel H, Gaduputi V, Sakam S, Kumar K, Chime C, Balar B

Therapeutics and Clinical Risk Management 2015, 11:1283-1289

Published Date: 27 August 2015

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

Mandernach MW, Beyth RJ, Rajasekhar A

Therapeutics and Clinical Risk Management 2015, 11:1273-1282

Published Date: 26 August 2015

Virus-induced secondary bacterial infection: a concise review

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2015, 11:1265-1271

Published Date: 24 August 2015

Value of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis

Sevuk U, Bahadir MV, Altindag R, Baysal E, Yaylak B, Ay N, Ayaz F, Demirtas E

Therapeutics and Clinical Risk Management 2015, 11:1243-1249

Published Date: 20 August 2015

Patient considerations in the management of ulcerative colitis – role of vedolizumab

Kothari M, Mudireddy P, Swaminath A

Therapeutics and Clinical Risk Management 2015, 11:1235-1242

Published Date: 19 August 2015

Pulmonary hypertension: diagnostic and therapeutic challenges

Bazan IS, Fares WH

Therapeutics and Clinical Risk Management 2015, 11:1221-1233

Published Date: 17 August 2015

Appendectomy in a child with cyclic neutropenia in profound neutropenic episode

Glavan N, Roganović J, Glavan-Gačanin L, Jonjić N

Therapeutics and Clinical Risk Management 2015, 11:1217-1219

Published Date: 17 August 2015

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

Kelliny M, Croarkin PE, Moore KM, Bobo WV

Therapeutics and Clinical Risk Management 2015, 11:1193-1212

Published Date: 12 August 2015

The relationship between eosinophilia and slow coronary flow

Altas Y, Kurtoglu E, Yaylak B, Baysal E, Ucaman B, Ugurlu HM, Karahan MZ, Altintas B, Adiyaman MS, Kaya İ, Erdolu U, Ozen K, Cakir C, Sevuk U

Therapeutics and Clinical Risk Management 2015, 11:1187-1191

Published Date: 12 August 2015

A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain

King JB, Schauerhamer MB, Bellows BK

Therapeutics and Clinical Risk Management 2015, 11:1163-1175

Published Date: 10 August 2015

Xerostomia induced by radiotherapy

Alimi D

Therapeutics and Clinical Risk Management 2015, 11:1149-1152

Published Date: 5 August 2015

The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients

Sittichanbuncha Y, Sricharoen P, Tangkulpanich P, Sawanyawisuth K

Therapeutics and Clinical Risk Management 2015, 11:1143-1147

Published Date: 4 August 2015

Cesarean scar pregnancy treated by curettage and aspiration guided by laparoscopy

Shu S, Luo X, Wang Z, Yao Y

Therapeutics and Clinical Risk Management 2015, 11:1139-1141

Published Date: 3 August 2015

Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers

ElHalawani H, Abdel-Rahman O

Therapeutics and Clinical Risk Management 2015, 11:1123-1132

Published Date: 28 July 2015

Massive hemorrhage management – a best evidence topic report

Vymazal T

Therapeutics and Clinical Risk Management 2015, 11:1107-1111

Published Date: 27 July 2015

Fluid accumulation threshold measured by acute body weight change after admission in general surgical intensive care units: how much should be concerning?

Chittawatanarat K, Pichaiya T, Chandacham K, Jirapongchareonlap T, Chotirosniramit N

Therapeutics and Clinical Risk Management 2015, 11:1097-1106

Published Date: 27 July 2015

Paclitaxel reduces formation of hypertrophic scars in the rabbit ear model

Huang LP, Wang GQ, Jia ZS, Chen JW, Wang G, Wang XL

Therapeutics and Clinical Risk Management 2015, 11:1089-1095

Published Date: 27 July 2015

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs

Moore N, Pollack C, Butkerait P

Therapeutics and Clinical Risk Management 2015, 11:1061-1075

Published Date: 15 July 2015

Vasopressors in septic shock: a systematic review and network meta-analysis

Zhou FH, Mao Z, Zeng XT, Kang HJ, Liu H, Pan L, Hou PC

Therapeutics and Clinical Risk Management 2015, 11:1047-1059

Published Date: 14 July 2015

Which people should take aspirin for primary prevention of cardiovascular disease?

Lozano R, Franco ME

Therapeutics and Clinical Risk Management 2015, 11:1043-1045

Published Date: 2 July 2015

Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis

Bartkowska-Śniatkowska A, Jończyk-Potoczna K, Zielińska M, Rosada-Kurasińska J

Therapeutics and Clinical Risk Management 2015, 11:1035-1041

Published Date: 2 July 2015

Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis

Tong X, Cao Y, Yu M, Han C

Therapeutics and Clinical Risk Management 2015, 11:1027-1033

Published Date: 2 July 2015

Comparative study on drug safety surveillance between medical students of Malaysia and Nigeria

Abubakar AR, Ismail S, Rahman NIA, Haque M

Therapeutics and Clinical Risk Management 2015, 11:1015-1025

Published Date: 30 June 2015

OnabotulinumtoxinA for chronic migraine: a critical appraisal

Gooriah R, Ahmed F

Therapeutics and Clinical Risk Management 2015, 11:1003-1013

Published Date: 29 June 2015

Canagliflozin-induced pancreatitis: a rare side effect of a new drug

Chowdhary M, Kabbani AA, Chhabra A

Therapeutics and Clinical Risk Management 2015, 11:991-994

Published Date: 26 June 2015

Optimal management of digital ulcers in systemic sclerosis

Abraham S, Steen V

Therapeutics and Clinical Risk Management 2015, 11:939-947

Published Date: 15 June 2015

Staphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 cases

Zhou JD, Huang H, Liu S, Yu P, Wan QQ

Therapeutics and Clinical Risk Management 2015, 11:933-937

Published Date: 12 June 2015

Neurogenic orthostatic hypotension – management update and role of droxidopa

Vijayan J, Sharma VK

Therapeutics and Clinical Risk Management 2015, 11:915-923

Published Date: 8 June 2015

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress

Ceriello A, La Sala L, De Nigris V, Pujadas G, Rondinelli M, Genovese S

Therapeutics and Clinical Risk Management 2015, 11:901-903

Published Date: 4 June 2015

Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma

Prosser TR, Bollmeier SG

Therapeutics and Clinical Risk Management 2015, 11:889-899

Published Date: 2 June 2015

Two cases of Paget’s disease of scrotum in biological brothers

Rao D, Zhu H, Yu K, Yu H, Xie L

Therapeutics and Clinical Risk Management 2015, 11:885-887

Published Date: 27 May 2015

Novel targeted therapies in chordoma: an update

Di Maio S, Yip S, Al Zhrani GA, Alotaibi FE, Al Turki A, Kong E, Rostomily R

Therapeutics and Clinical Risk Management 2015, 11:873-883

Published Date: 26 May 2015

The incidence and risk factors of peripherally inserted central catheter-related infection among cancer patients

Gao Y, Liu Y, Ma X, Wei L, Chen W, Song L

Therapeutics and Clinical Risk Management 2015, 11:863-871

Published Date: 22 May 2015

Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization

Fu Y, Chen C, Feng S, Cheng X, Wang X, Xie X, Lü W

Therapeutics and Clinical Risk Management 2015, 11:851-856

Published Date: 21 May 2015

Transtracheal single-point stent fixation in posttracheotomy tracheomalacia under cone-beam computer tomography guidance by transmural suturing with the Berci needle – a perspective on a new tool to avoid stent migration of Dumon stents

Hohenforst-Schmidt W, Linsmeier B, Zarogoulidis P,Freitag L, Darwiche K, Browning R, Turner JF, Huang H, Li Q, Vogl T, Zarogoulidis K, Brachmann J, Rittger H

Therapeutics and Clinical Risk Management 2015, 11:837-850

Published Date: 22 May 2015

Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients

Chow KM, Szeto CC, Lai FM, Luk CC, Kwan BC, Leung CB, Li PK

Therapeutics and Clinical Risk Management 2015, 11:829-835

Published Date: 19 May 2015

Association of low potassium diet and folic acid deficiency in patients with CKD

Hassan K

Therapeutics and Clinical Risk Management 2015, 11:821-827

Published Date: 18 May 2015

Testosterone levels of children with a diagnosis of developmental stuttering

Selçuk EB, Erbay LG, Özcan ÖÖ, Kartalcı S, Batcıoğlu K

Therapeutics and Clinical Risk Management 2015, 11:793-798

Published Date: 14 May 2015

The role of delamanid in the treatment of drug-resistant tuberculosis

Lewis JM, Sloan DJ

Therapeutics and Clinical Risk Management 2015, 11:779-791

Published Date: 13 May 2015

To what extent is clinical and laboratory information used to perform medication reviews in the nursing home setting? the CLEAR study

Mestres Gonzalvo C, Hurkens KPGM, de Wit HAJM, van Oijen BPC, Janknegt R, Schols JMGA, Mulder WJ, Verhey FR, Winkens B, van der Kuy PHM

Therapeutics and Clinical Risk Management 2015, 11:767-777

Published Date: 8 May 2015

Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients

Suno M, Endo Y, Nishie H, Kajizono M, Sendo T, Matsuoka J

Therapeutics and Clinical Risk Management 2015, 11:751-757

Published Date: 8 May 2015

The role of empagliflozin in the management of type 2 diabetes by patient profile

Hedrington MS, Davis SN

Therapeutics and Clinical Risk Management 2015, 11:739-749

Published Date: 5 May 2015

Recurrent respiratory papillomatosis: current and future perspectives

Carifi M, Napolitano D, Morandi M, Dall’Olio D

Therapeutics and Clinical Risk Management 2015, 11:731-738

Published Date: 5 May 2015

Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron

Zhou M, Popovic M, Pasetka M, Pulenzas N, Ahrari S, Chow E, DeAngelis C

Therapeutics and Clinical Risk Management 2015, 11:713-729

Published Date: 5 May 2015

Optimal management of constipation associated with irritable bowel syndrome

Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V

Therapeutics and Clinical Risk Management 2015, 11:691-703

Published Date: 30 April 2015

Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma

Dogan B, Erol MK, Toslak D, Coban DT, Bulut M, Cengiz A, Sarı ES

Therapeutics and Clinical Risk Management 2015, 11:683-689

Published Date: 30 April 2015

Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A

Therapeutics and Clinical Risk Management 2015, 11:659-667

Published Date: 24 April 2015

Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia

Kabbara WK, Ramadan WH, Rahbany P, Al-Natour S

Therapeutics and Clinical Risk Management 2015, 11:639-647

Published Date: 22 April 2015

A novel missense KIT mutation causing piebaldism in one Chinese family associated with café-au-lait macules and intertriginous freckling

Jia WX, Xiao XM, Wu JB, Ma YP, Ge YP, Li Q, Mao QX, Li CR

Therapeutics and Clinical Risk Management 2015, 11:635-638

Published Date: 21 April 2015

Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures [Corrigendum]

Patel RR, Liang SY, Koolwal P, Kuhlmann FM

Therapeutics and Clinical Risk Management 2015, 11:633-634

Published Date: 20 April 2015

Adalimumab in the management of Behçet’s disease

Ueda A, Takeno M, Ishigatsubo Y

Therapeutics and Clinical Risk Management 2015, 11:611-619

Published Date: 13 April 2015

Update on the emerging role of telavancin in hospital-acquired infections

Nnedu ON, Pankey GA

Therapeutics and Clinical Risk Management 2015, 11:605-610

Published Date: 13 April 2015

A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome

Pinto-Bonilla JC, del Olmo-Jimeno A, Llovet-Osuna F, Hernández-Galilea E

Therapeutics and Clinical Risk Management 2015, 11:595-603

Published Date: 13 April 2015

Copeptin: a new predictor for severe obstructive sleep apnea

Çınarka H, Kayhan S, Karataş M, Yavuz A, Gümüş A, Özyurt S, Cüre MC, Şahin Ü

Therapeutics and Clinical Risk Management 2015, 11:589-594

Published Date: 10 April 2015

Pneumoscrotum: report of two different cases and review of the literature

Cochetti G, Barillaro F, Cottini E, D’Amico F, Pansadoro A, Pohja S, Boni A, Cirocchi R, Grassi V, Mancuso R, Silvi E, Ioannidou K, Egidi MG, Poli G, Mearini E

Therapeutics and Clinical Risk Management 2015, 11:581-587

Published Date: 9 April 2015

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit

Maggiore C, Vazquez JA, Guervil DJ, Ramani A, Jandourek A, Cole P, Friedland HD

Therapeutics and Clinical Risk Management 2015, 11:557-563

Published Date: 2 April 2015

Profile of pomalidomide and its potential in the treatment of myelofibrosis

Gowin KL, Mesa RA

Therapeutics and Clinical Risk Management 2015, 11:549-556

Published Date: 2 April 2015

Prostanoid therapies in the management of pulmonary arterial hypertension

LeVarge BL

Therapeutics and Clinical Risk Management 2015, 11:535-547

Published Date: 31 March 2015

Alemtuzumab for the treatment of multiple sclerosis

Willis MD, Robertson NP

Therapeutics and Clinical Risk Management 2015, 11:525-534

Published Date: 31 March 2015

The unsolved case of “bone-impairing analgesics”: the endocrine effects of opioids on bone metabolism

Coluzzi F, Pergolizzi J, Raffa RB, Mattia C

Therapeutics and Clinical Risk Management 2015, 11:515-523

Published Date: 31 March 2015

Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection

Gao F, Ye QF, Wan QQ, Liu S, Zhou JD

Therapeutics and Clinical Risk Management 2015, 11:501-505

Published Date: 26 March 2015

P-wave and QT dispersion in patients with conversion disorder

Izci F, Hocagil H, Izci S, Izci V, Koc MI, Acar RD

Therapeutics and Clinical Risk Management 2015, 11:475-480

Published Date: 26 March 2015

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q

Therapeutics and Clinical Risk Management 2015, 11:449-467

Published Date: 19 March 2015

Epidemiology of Japanese encephalitis: past, present, and future prospects

Wang H, Liang G

Therapeutics and Clinical Risk Management 2015, 11:435-448

Published Date: 19 March 2015

Clinical use of pasireotide for Cushing's disease in adults

Ceccato F, Scaroni C, Boscaro M

Therapeutics and Clinical Risk Management 2015, 11:425-434

Published Date: 17 March 2015

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

Vázquez-Espinosa E, Girón RM, Gómez-Púnter RM, García-Castillo E, Valenzuela C, Cisneros C, Zamora E, García-Pérez FJ, Ancochea J

Therapeutics and Clinical Risk Management 2015, 11:407-415

Published Date: 12 March 2015

Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?

Asaoka D, Nagahara A, Shimada Y, Matsumoto K, Ueyama H, Matsumoto K, Nakagawa Y, Takeda T, Tanaka I, Sasaki H, Osada T, Hojo M, Watanabe S

Therapeutics and Clinical Risk Management 2015, 11:381-391

Published Date: 6 March 2015

Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: a pilot trial

Oh S, Maruyama T, Eguchi K, Shida T, Arai E, Isobe T, Okamoto Y, Shoda J

Therapeutics and Clinical Risk Management 2015, 11:371-380

Published Date: 4 March 2015

Update on therapeutic management of idiopathic pulmonary fibrosis

Tzouvelekis A, Bonella F, Spagnolo P

Therapeutics and Clinical Risk Management 2015, 11:359-370

Published Date: 3 March 2015

Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study

Hsiao PC, Liu JT, Lin CL, Chou W, Lu SR

Therapeutics and Clinical Risk Management 2015, 11:349-358

Published Date: 27 February 2015

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

Aguirre Valadez J, García Juárez I, Rincón Pedrero R, Torre A

Therapeutics and Clinical Risk Management 2015, 11:329-338

Published Date: 27 February 2015

Role of physiotherapy and patient education in lymphedema control following breast cancer surgery

Lu SR, Hong RB, Chou W, Hsiao PC

Therapeutics and Clinical Risk Management 2015, 11:319-327

Published Date: 25 February 2015

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients

Chen BL, Zhang YZ, Luo JQ, Zhang W

Therapeutics and Clinical Risk Management 2015, 11:309-318

Published Date: 24 February 2015

Optimal management of Ménière’s disease

Foster CA

Therapeutics and Clinical Risk Management 2015, 11:301-307

Published Date: 25 February 2015

Advances in diagnosis and treatment of trigeminal neuralgia

Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F

Therapeutics and Clinical Risk Management 2015, 11:289-299

Published Date: 24 February 2015

Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients

Sabry D, Al-Ghussein MAS, Hamdy G, Abul-Fotouh A, Motawi T, El Kazaz AY, Eldemery A, Shaker M

Therapeutics and Clinical Risk Management 2015, 11:279-288

Published Date: 19 February 2015

Reducing drug–herb interaction risk with a computerized reminder system

Lin SS, Tsai CL, Tu CY, Hsieh CL

Therapeutics and Clinical Risk Management 2015, 11:247-253

Published Date: 16 February 2015

PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk

Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ

Therapeutics and Clinical Risk Management 2015, 11:237-245

Published Date: 13 February 2015

Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients

Liang LB, Zhu X, Yan LB, Du LY, Liu C, Chen LY, Liao J, Tang H

Therapeutics and Clinical Risk Management 2015, 11:229-235

Published Date: 13 February 2015

Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures

Patel RR, Liang SY, Koolwal P, Kuhlmann FM

Therapeutics and Clinical Risk Management 2015, 11:217-228

Published Date: 12 February 2015

Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac disease

Anakwue RC, Onwubere BJ, Ikeh V, Anisiuba B, Ike S, Anakwue AC

Therapeutics and Clinical Risk Management 2015, 11:189-200

Published Date: 5 February 2015

Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage

Pinna R, Campus G, Cumbo E, Mura I, Milia E

Therapeutics and Clinical Risk Management 2015, 11:171-188

Published Date: 4 February 2015

Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation

Liu Y, Gao Y, Wei L, Chen W, Ma X, Song L

Therapeutics and Clinical Risk Management 2015, 11:153-160

Published Date: 29 January 2015

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes

Chotirmall SH, Al-Alawi M, McEnery T, McElvaney NG

Therapeutics and Clinical Risk Management 2015, 11:143-151

Published Date: 29 January 2015

Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy

Peng P, Gui T, Liu X, Chen W, Liu Z

Therapeutics and Clinical Risk Management 2015, 11:137-142

Published Date: 27 January 2015

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

Chinwong D, Patumanond J, Chinwong S, Siriwattana K, Gunaparn S, Hall JJ, Phrommintikul A

Therapeutics and Clinical Risk Management 2015, 11:127-136

Published Date: 23 January 2015

Neural circuits in anxiety and stress disorders: a focused review

Duval ER, Javanbakht A, Liberzon I

Therapeutics and Clinical Risk Management 2015, 11:115-126

Published Date: 23 January 2015

Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease

Kunisawa T, Yamagishi A, Suno M, Nakade S, Honda N, Kurosawa A, Sugawara A, Tasaki Y, Iwasaki H

Therapeutics and Clinical Risk Management 2015, 11:107-114

Published Date: 17 January 2015

Tapentadol extended release in the management of peripheral diabetic neuropathic pain

Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM

Therapeutics and Clinical Risk Management 2015, 11:95-105

Published Date: 14 January 2015

Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis

Huang Y, Feng JF, Liu JS, Chen QX

Therapeutics and Clinical Risk Management 2015, 11:89-94

Published Date: 14 January 2015

Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension

Yagi S, Takashima A, Mitsugi M, Wada T, Hotchi J, Aihara K, Hara T, Ishida M, Fukuda D, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M

Therapeutics and Clinical Risk Management 2015, 11:83-88

Published Date: 12 January 2015

Management of bipolar I depression: clinical utility of lurasidone

Findlay LJ, El-Mallakh P, El-Mallakh RS

Therapeutics and Clinical Risk Management 2015, 11:75-81

Published Date: 8 January 2015

Rhegmatogenous retinal detachment due to a macular hole in a patient with pars planitis: a case report

Stavrakas P, Androu AA, Tranos P, Kontou E, Milia M, Georgalas I

Therapeutics and Clinical Risk Management 2015, 11:59-61

Published Date: 30 December 2014

The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease

Bal MV, Olgun A, Abaslı D, Özdemir A. Kürşaklıoğlu H, Göktepe AS, Kurt Í

Therapeutics and Clinical Risk Management 2015, 11:53-58

Published Date: 30 December 2014

Diagnosis and management of xerostomia and hyposalivation

Villa A, Connell CL, Abati S

Therapeutics and Clinical Risk Management 2015, 11:45-51

Published Date: 22 December 2014

Treatment of adult-onset Still’s disease: a review

Jamilloux Y, Gerfaud-Valentin M, Henry T, Sève P

Therapeutics and Clinical Risk Management 2015, 11:33-43

Published Date: 22 December 2014

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

Zafar MI, Ai X, Shafqat RA, Gao F

Therapeutics and Clinical Risk Management 2015, 11:27-32

Published Date: 19 December 2014

Bayesian imperfect information analysis for clinical recurrent data

Chang CK, Chang CC

Therapeutics and Clinical Risk Management 2015, 11:17-26

Published Date: 19 December 2014

Patient risk factors for developing a drug-related problem in a cardiology ward

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J

Therapeutics and Clinical Risk Management 2015, 11:9-15

Published Date: 17 December 2014